Previous 10 | Next 10 |
home / stock / rxrx / rxrx articles
On Tuesday, Cathie Wood-led Ark Invest made significant adjustments to its portfolio, offloading a substantial number of shares in Tesla Inc (NASDA...
On Monday, Cathie Wood-led Ark Invest made a notable investment in Palantir Technologies Inc (NYSE:PLTR), a move that comes as the AI sector gains ...
Recursion Pharmaceuticals Inc (NASDAQ:RXRX) shares are trading lower Thursday after the company announced a proposed offering of its common st...
Recursion Pharmaceuticals Inc (NASDAQ:RXRX) shares are trading lower in Wednesday’s after-hours session after the company announced a propose...
Shares of clinical stage biotech company Recursion Pharmaceuticals Inc (NASDAQ:RXRX) are trading higher Tuesday. The company’s CEO Chris Gibs...
Recursion Pharmaceuticals Inc (NASDAQ:RXRX) shares traded higher Monday after the company provided updated guidance and partnership updates at its ...
U.S. stock futures were mixed this morning, with the Nasdaq futures gaining around 0.2% on Tuesday. Shares of NextEra Energy, Inc. (NYSE:NEE) fell ...
On CNBC's “Mad Money Lightning Round,” Jim Cramer said Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is a “terrific specR...
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) made waves Monday with the announcement of the completion of its groundbreaking BioHive-2 supercomput...
News, Short Squeeze, Breakout and More Instantly...
Recursion Pharmaceuticals Inc. Company Name:
RXRX Stock Symbol:
NASDAQ Market:
Recursion Pharmaceuticals Inc. Website:
Salt Lake City, June 26, 2024 (GLOBE NEWSWIRE) -- Recursion Pharmaceuticals, Inc. (“ Recursion ”) (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today announced the pricing of its underwritten public offering of 30,769,...